Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Resverlogix : IIROC Trading Halt - RVX

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:32pm CET

TORONTO, Oct. 13, 2017 /CNW/ - The following issues have been halted by IIROC:

Company: Resverlogix Corp.

TSX Symbol: RVX (all issues)

Reason: Pending News

Halt Time (ET): 9:16: AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
12/07 Resverlogix Repays $68.8 Million Loan
12/05 RESVERLOGIX : Closes Previously Announced $87 Million Private Placement with She..
12/04 Resverlogix Closes Previously Announced $87 Million Private Placement with S..
12/04 RESVERLOGIX : Closes Previously Announced $87 Million Private Placement with She..
11/02 RESVERLOGIX : Announces Fifth Positive Recommendation From Data Safety Monitorin..
11/02 Resverlogix Announces Participation in Upcoming Conferences
11/01 Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitori..
10/26 RESVERLOGIX : Announces right of first refusal agreement with hepalink usa inc
10/25 RESVERLOGIX : Announces Right of First Refusal Agreement with Hepalink USA Inc.
10/24 RESVERLOGIX : Announces Right of First Refusal Agreement with Hepalink USA Inc.
More news
News from SeekingAlpha
11/08 Resverlogix (RVXCF) Presents At BIO-Europe-23rd Annual International Partneri..
10/22 WEEK IN REVIEW : WuXi AppTec Acquires U.S.-Global Clinical CRO
10/18 Resverlogix (RVXCF) Presents At 2017 BIO Investor Forum - Slideshow
10/13 Resverlogix secures $87M private capital raise
07/16 WEEK IN REVIEW : BGI Genomics Completes $81-Million Chi-Next IPO
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.31.74%196
CELLTRION, INC.--.--%22 034
IQVIA HOLDINGS INC32.81%21 333
INCYTE CORPORATION-6.46%20 382
LONZA GROUP54.74%19 270
ALNYLAM PHARMACEUTICALS, INC.239.21%12 871